Song Tao, Xia Wei, Shao Ningsheng, Zhang Xu, Wang Chunyang, Wu Yiguang, Dong Jun, Cai Wei, Li Hongzhao
Department of Urology, Clinical Division of Surgery, Chinese PLA General Hospital, Beijing, China.
Asian Pac J Cancer Prev. 2010;11(4):905-11.
The urothelial carcinoma is the most common pathological type of bladder tumor. Creation of lists of miRNAs differentially expressed between this tumor type and normal tissue might help identify new diagnostic and prognostic markers. We therefore performed the present miRNA microarray analysis with 25 cases of bladder urothelial carcinomas and adjacent normal bladder tissue. The results showed a panel of 51 differentially expressed miRNAs with at least 2-fold differences in expression compared with the normal controls, including 20 up-regulated and 31 down-regulated examples. The expression levels of ten of the top dysregulated miRNAs, mir-1, mir-145, mir-143, mir-100, mir-200b, mir-708, mir-133a, mir-133b, mir-125b and mir-99 were experimentally verified using real-time RT-PCR analysis. These findings suggest that these miRNAs may be involved in bladder urothelial carcinoma pathogenesis and have potential as biomarkers.
尿路上皮癌是膀胱肿瘤最常见的病理类型。列出该肿瘤类型与正常组织之间差异表达的miRNA清单可能有助于识别新的诊断和预后标志物。因此,我们对25例膀胱尿路上皮癌及相邻正常膀胱组织进行了本次miRNA微阵列分析。结果显示,与正常对照相比,有一组51个差异表达的miRNA,其表达差异至少为2倍,其中20个上调,31个下调。使用实时RT-PCR分析对失调最严重的10个miRNA(mir-1、mir-145、mir-143、mir-100、mir-200b、mir-708、mir-133a、mir-133b、mir-125b和mir-99)的表达水平进行了实验验证。这些发现表明,这些miRNA可能参与膀胱尿路上皮癌的发病机制,并具有作为生物标志物的潜力。